Novozymes A/S (NVZMF)
OTCMKTS · Delayed Price · Currency is USD
68.98
-1.11 (-1.59%)
Jul 18, 2025, 10:23 AM EDT
Novozymes Revenue
Novozymes had revenue of 1.08B EUR in the quarter ending March 31, 2025, with 26.26% growth. This brings the company's revenue in the last twelve months to 4.06B, up 53.93% year-over-year. In the year 2024, Novozymes had annual revenue of 3.83B with 59.58% growth.
Revenue (ttm)
4.06B EUR
Revenue Growth
+53.93%
P/S Ratio
7.40
Revenue / Employee
383.44K EUR
Employees
10,582
Market Cap
32.43B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
The Monarch Cement Company | 256.69M |
Gold Reserve | 3.17M |
Panamera Holdings | 212.04K |
Rubber Leaf | 3.98M |
Cardinal Ethanol, LLC | 350.34M |
Venator Materials | 1.56B |
Novozymes News
- 6 weeks ago - Novonesis: Industry Leader With Defensive Characteristics And Solid Growth - Seeking Alpha
- 2 months ago - Novonesis A/S (NVZMF) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Novo Nordisk Stakeholder Reports $9 Billion In Income Due To Robust Weight Loss Drug Sales - Benzinga
- 3 months ago - Tariffs create uncertainty and pause investment, says Novonesis CEO - CNBC
- 5 months ago - Novonesis A/S (NVZMF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Novonesis: Still Too Expensive - Seeking Alpha
- 6 months ago - Exciting prospects in bioenergy and functional foods, Novonesis CEO says - CNBC
- 8 months ago - Top 3 global stocks poised for 40% gains by 2025 - Invezz